JSJeena Sikho Lifecare544476Subsidiary or JV

Board approves proposal to incorporate Ayugenomics Private Limited as a subsidiary

Jeena Sikho Lifecare's Board has approved a proposal to incorporate a subsidiary in India, proposed name Ayugenomics Private Limited.

By ScoutQuest · Wed 4 Nov 2026, 4:49 PM IST · 2 min read

Proposed authorised share capital

Rs. 5,00,000, made up of 50,000 equity shares of ₹10 each

Proposed holding and subscription

60% of the equity share capital; 30,000 equity shares for Rs. 3,00,000, in cash

Proposed subsidiary business

genomics and omics sciences combined with Ayurveda and other AYUSH systems, including tests, diagnostics and AI-based platforms

Board approval, not yet a company

• The Board of Jeena Sikho Lifecare Ltd met on Wednesday, November 04, 2026, from 03:15 P.M. to 03:50 P.M., and approved the proposal to incorporate a subsidiary in India.
• The proposed name is Ayugenomics Private Limited. The entity is yet to be incorporated, so the update records the date of incorporation as not applicable.
• The proposal is subject to the requisite statutory approvals and completion of applicable incorporation formalities.

Ownership and money

• The company proposes to hold 60% of the equity share capital of the proposed subsidiary.
• The proposed authorised share capital is Rs. 5,00,000, comprising 50,000 equity shares of ₹10 each.
• The company will subscribe 30,000 equity shares at Rs. 10 per share, a total of Rs. 3,00,000, through the cash/banking channel.
• Upon incorporation and subscription to its equity share capital, the entity will become a subsidiary and, post incorporation, a related party of the listed company.

What the new company is meant to do

• Research, development, testing, diagnostics and clinical services that combine genomics and allied omics sciences with Ayurveda and other AYUSH systems of medicine.
• Genomics-based panels, tests and software, clinical decision-support and artificial intelligence platforms, clinical databases and registries.
• Clinical studies and evidence-generation programmes.
• Developing, validating, manufacturing, licensing and commercialising evidence-based herbal, nutraceutical and botanical products and treatment protocols.
• Wellness, preventive-health, training and certification programmes.
• Working with hospitals, government and state programmes, and national and international institutions, including in Japan and other overseas markets.
• Seeking patents and regulatory approvals and registrations in India and abroad, including CDSCO and the US FDA, and owning and commercialising the intellectual property it creates.

Regulatory position

• No governmental or regulatory approvals are presently required; any applicable approvals are to be obtained as and when required.

Points a retail investor may note

• The proposed subsidiary is a separate entity in which the listed company would hold 60%, so the genomics-plus-Ayurveda business would sit alongside the parent rather than inside it.
• The stated cost of the 60% stake is Rs. 3,00,000 for 30,000 shares of Rs. 10 each.
• The products and activities described are the proposed objects of a company that is yet to be incorporated, not existing operations.

Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.

About ScoutQuest · Logos provided by Logo.dev